Genetic Technologies Limited (ASX:GTG)

Mr. Rubinstein was appointed to the Board on 31 January 2018 and appointed as Chairman in April 2020. He has over 20 years of experience in early-stage technology commercialisation through to public listings on the ASX. He is a lawyer, having worked at a large national firm prior to moving in-house at Montech, the commercial arm of Monash University. Mr. Rubinstein has had significant exposure to the creation, launch, and management of a diverse range of technology companies in biotech, digital payments, and renewable energy. Mr. Rubinstein is also a Non-Executive Director of DigitalX Limited (ASX: DCC).

Dr. Wakefield was appointed to the Board on 24 September 2014. He started Safetech in 1985 and over the next 25 years, Safetech became a force in the Australian material handling and lifting equipment market, designing and manufacturing a wide range of industrial products. In 1993, he left medicine to become the full-time CEO of Safetech. In 2006 Safetech was awarded the Telstra Australian National Business of the Year. In 2013 Safetech merged and ultimately acquired Tieman Materials Handling.

Dr. Wakefield continues as the CEO of Safetech. It is Australia’s largest manufacturer and supplier of dock equipment, freight hoists and custom lifting solutions. Safetech employs approximately 100 people. Dr. Wakefield has been a biotech investor for more than 20 years.

Dr. Muchnicki was appointed to the Board on 31 January 2018 and acted as Interim Chief Executive Officer from September 2019 till the appointment of Mr. Simon Morriss to the role. George graduated from Monash University and has held positions in private practice for over 25 years and was Head of Student Health at The University of Melbourne. For the past 14 years, he has been involved in commercialisation and funding R&D in the biotechnology sector from gene silencing to regenerative medicine.

Dr. Muchnicki brings with him strong commercial and medical skills, including broad interests in software development, blockchain and sustainable building materials. He is a co-founder and Non-Executive Director of Speed Panel Holdings a world leader in fire rated and acoustic wall solutions. He is also the co-founder of Candlebets, a software development company that is creating blockchain enabled platforms for the gaming industry.

Mark is an experienced CFO and non-executive director with extensive ASX-listed experience. He has held senior roles at Cochlear, Aristocrat, Coca-Cola Amatil, and Goodman Fielder. Currently, he is a non-executive director and Audit and Risk Committee chair at Opyl Limited, and has served in similar roles at Respiri and Orcoda Limited.

Mark began his career at EY and has since held executive roles, including CFO at Wiseway Group, where he led its ASX IPO, and CFO at Anteris Technologies. He also served as Director of Finance and IT for Asia Pacific at Cochlear.

With over 25 years in Asia, Mark has expertise in strategy, M&A, corporate finance, governance, and risk management, focusing on high-growth and early-stage companies.